GLP-1 and Sleep Apnea: Half of Men in the Trial Had Their Sleep Apnea Disappear Completely

Your body produces about 70% of its testosterone during deep sleep — specifically during the slow-wave phases that happen in the second half of the night. This isn't a small detail. It means that the quality and depth of your sleep is directly tied to how much testosterone you make. Sleep apnea wrecks this in two ways. First, each apnea event briefly wakes your brain, which fragments deep sleep into shallow sleep. Second, each event triggers your stress system — cortisol goes up, and elevated cortisol tells your body to suppress testosterone production. Men with untreated sleep apnea consistently show lower morning testosterone than matched controls. Many men who get a testosterone test showing low-normal levels actually have sleep apnea as the underlying driver, not a problem with their hormone-producing system. Treating the apnea often restores testosterone without any hormonal intervention at all.

The SURMOUNT-OSA trial enrolled 469 adults with moderate-to-severe obstructive sleep apnea who were not using CPAP. They were randomly assigned to tirzepatide or placebo. At the end of the trial, tirzepatide users saw their apnea-hypopnea index (AHI — the number of breathing interruptions per hour) fall by 30-40%. More dramatically, 51% reached an AHI below 5 events per hour, which is the clinical definition of normal. Their sleep apnea was gone. The mechanism is straightforward: the fat that collects in the tissues around your throat and tongue narrows your airway. Lose that fat — which GLP-1 drugs do very efficiently in the neck and face — and the airway opens. There's nothing complicated about the plumbing here. The airway gets bigger because the surrounding fat pads shrink. What's remarkable is how complete the resolution was for so many participants.

Here's something your sleep doctor may not tell you when you start a GLP-1 drug: as you lose weight and your sleep apnea improves, your CPAP pressure setting may become wrong — specifically, too high. Your CPAP was calibrated to the airway you had when you were heavier. As that airway opens up, the same pressure that was appropriate before can now force too much air in. The result is air swallowing (aerophagia), which causes bloating, burping, and discomfort. Or it causes mask leaks and new sleep fragmentation. Or both. The fix is a pressure re-titration study — a repeat sleep study to recalibrate your CPAP to your current airway. This should happen roughly every 20 pounds of weight loss. If you're on a GLP-1 drug and using CPAP and your sleep suddenly feels worse, this is likely why. Tell your sleep doctor you're losing significant weight on a GLP-1 drug and ask when to schedule re-titration.

About 40% of men with significant excess weight also have GERD — gastroesophageal reflux disease. Acid from the stomach enters the esophagus, especially when lying down. This disrupts sleep, but in a way that's hard to track because the reflux often doesn't produce dramatic heartburn — it just causes micro-arousals and lighter sleep across the night. GLP-1 drugs improve GERD through two mechanisms: they slow down how quickly the stomach empties (which reduces the pressure that drives reflux upward), and they help strengthen the muscle at the bottom of the esophagus that's supposed to keep acid out. For men whose sleep was being disrupted by nighttime reflux without obvious daytime symptoms, GLP-1 therapy often produces a noticeable improvement in sleep quality that gets credited to the weight loss but has a more direct cause. Better sleep architecture means better hormonal recovery — the two goals reinforce each other.